|1.||Okumura, Ken: 1 article (08/2015)|
|2.||Mitamura, Hideo: 1 article (08/2015)|
|3.||Takatsuki, Seiji: 1 article (08/2015)|
|4.||Nagai, Takayuki: 1 article (08/2015)|
|5.||Watanabe, Atsuyuki: 1 article (08/2015)|
|6.||Joutsi-Korhonen, Lotta: 1 article (07/2015)|
|7.||Lemponen, Marja: 1 article (07/2015)|
|8.||Hjemdahl, Paul: 1 article (07/2015)|
|9.||Rönquist-Nii, Yuko: 1 article (07/2015)|
|10.||Lassila, Riitta: 1 article (07/2015)|
08/01/2015 - "The study was aimed at evaluating the efficacy of dabigatran (Dabi) treatment in preventing peri-ECV stroke. "
12/01/2014 - "There were no strokes reported during follow-up and 3 TIAs: 2 in the VKA group and 1 in the DABI group not resulting in a significant difference between the groups. "
12/01/2014 - "In these patients there were no strokes seen during follow-up and 2 TIAs in the DABI group. "
08/01/2015 - "Two patients had a stroke 3 and 15 days after ECV, and one had a major large intestine bleeding episode during Dabi therapy. "
|3.||Atherosclerotic Plaque (Atheroma)
11/01/2012 - "Dabigatran etexilate attenuated increased atherosclerotic plaque formation [ApoE(-/-) Dabi: 16.1±3.8% of ApoE(-/-) control; p<0.001], decreased collagen content [ApoE(-/-) Dabi: 49.1±10% of ApoE(-/-) control; p=0.01], and ROS production in dihydroethidium staining [ApoE(-/-) Dabi: 46.3±5.4% of ApoE(-/-) control; p=0.005] in parallel to an improvement of endothelial function [ApoE(-/-) control 42.6±2.7 versus ApoE(-/-) Dabi 62.9±3.3% of phenylephrine-induced contraction; p=0.001] at 100 μmol carbachol. "
08/01/2015 - "Older patients with a higher CHADS2 score receiving a lower Dabi dosage were more likely to develop LA thrombus, which was resolved with a prolonged or increased dosage. "
08/01/2015 - "LA thrombus developed in 4% of patients with AF receiving Dabi. "
08/01/2015 - "Of the eight patients with LA thrombus, one had LA thrombus during a Dabi 150 mg b.i.d treatment, whereas the remaining seven were receiving 110 mg b.i.d for 3 weeks or longer. "
08/01/2015 - "A retrospective survey of the incidence and fate of left atrial (LA) thrombus during Dabi therapy in patients with AF was conducted between December 2012 and January 2013 by the Japanese Heart Rhythm Society. "
08/01/2015 - "In 6 of the 8 patients with LA thrombus, a second TEE was performed, revealing complete resolution of LA thrombus in five; among these five patients, one received Dabi dosage of 150 mg b.i.d unchanged, two received an increased dosage from 110 mg to 150 mg b.i.d, and two were switched to warfarin. "
|2.||Adenosine Diphosphate (ADP)
|8.||Apolipoproteins E (ApoE)